Using advanced imaging techniques to improve diagnosis and treatment of autoimmune epilepsy
TSPO-PET and MRI Imaging as Novel Imaging Tools for Autoimmune Epilepsy
This study is looking at new imaging techniques to help doctors better understand and diagnose autoimmune epilepsy by comparing brain scans of patients with this condition to those with other types of epilepsy and healthy people, with the goal of finding helpful markers for treatment.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University School of Medicine NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11079478 on NIH RePORTER |
What this research studies
This research investigates the use of novel imaging methods, specifically TSPO-PET and MRI, to better understand and diagnose autoimmune epilepsy. By visualizing microglial activation and blood-brain barrier disruption, the study aims to identify biomarkers that can guide treatment decisions for patients with this condition. The research will involve comparing imaging results from patients with autoimmune epilepsy to those with other types of epilepsy and healthy individuals. This approach seeks to enhance the accuracy of diagnosis and the effectiveness of targeted therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with autoimmune epilepsy, particularly those who are autoantibody positive or clinically suspected to have the condition.
Not a fit: Patients with epilepsy that is not autoimmune in nature may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate diagnoses and improved treatment options for patients with autoimmune epilepsy.
How similar studies have performed: Previous research has shown promise in using imaging techniques to study neuroinflammatory conditions, suggesting that this approach may yield valuable insights.
Where this research is happening
New York, United States
- New York University School of Medicine — New York, United States (Active)
Researchers
- Principal investigator: Steriade, Claude — New York University School of Medicine
- Study coordinator: Steriade, Claude
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.